T helper 17 cell immune response (Th17 immune response)

The T helper 17 cell immune response refers to the collective actions of a specialized subset of CD4+ T cells known as Th17 cells. These cells are defined by their production of pro-inflammatory cytokines such as interleukin‑17A (IL‑17A), IL‑21, IL‑22, and granulocyte-macrophage colony-stimulating factor. The primary function of the Th17-mediated immune response is to protect mucosal surfaces from extracellular bacteria and fungi by recruiting neutrophils and promoting inflammation at sites like the gut and lungs. Differentiation into the Th17 lineage occurs in naive CD4+ T cells upon stimulation with specific cytokines—primarily transforming growth factor beta (TGFβ) combined with interleukin 6 or interleukin 21—which activate STAT3 signaling pathways leading to expression of key transcription factors such as RORγt. While essential for host defense at barrier sites, aberrant or excessive activation of the Th17 pathway has been implicated in numerous autoimmune diseases due to its potent pro-inflammatory effects. The "Th17 immune response" is therefore not a single molecular target but rather describes an entire immunological process involving multiple molecules—including receptors like IL‑23R—and cellular interactions within adaptive immunity[1][3]. Because "T helper cell type 17 immune response" refers to a biological process rather than a discrete molecule or receptor that can be directly targeted by drugs in the conventional sense, it should not be classified as a therapeutic target per se. “Th~h~7 cells play an important role in maintaining mucosal barriers... Their main effector cytokines are IL‐l7A, IL‐l7F... Aberrant activation has been linked to pathogenesis of various autoimmune diseases.” [1][3] Note: This entry is marked `is_incorrect: true` because it describes an *immune process* rather than a specific molecular entity suitable for direct pharmacological targeting. For structured data purposes focused on drug targets/receptors/enzymes/etc., use more precise entities such as "Interleukin‐23 receptor," "Interleukin‐6 receptor," or "Retinoic acid–related orphan receptor gamma t" when referring to components involved in regulating this pathway.

Other names

Th17 cell-mediated immunityT helper type 17 responseTh17 pathway activationInterleukin-17-producing T cell response